Clinical Trials Browser

Phase 1/2 × Celecoxib × 90 days × Clear all

NCT00159484 2026-05-28

Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer

Phase 1/2 Completed

75 enrolled 25 charts

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms